To date, this is the only product that MXC has come up with that actually works. Why has it taken 5 years to get to this point - and why has MXC not pushed this product harder and faster.
Highlights
• CannEpil®, MGC Pharma’s Investigational Medicinal Product (“IMP”) has now been
successfully imported and received by its first patients in the United Kingdom.
• The first UK patient has received CannEpil® through the ‘I AM Billy Foundation’, supporting
the RESCAS study.
• Additionally, the Company has delivered CannEpil® to its first patient in the UK via the Named
Patient Request programme.
• This follows the announcement on 11 April 2023 that CannEpil® was now available in the
United Kingdom via Named Patient Request, and available to be prescribed by doctors on
The General Medical Council (“GMC”) specialist register across the UK.
• CannEpil® is in the process of a clinical development programme for patients suffering from
refractory (or drug-resistant) epilepsy.
- Forums
- ASX - By Stock
- RGT
- Ann: First CannEpil Delivered to UK Patients
Ann: First CannEpil Delivered to UK Patients, page-2
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
35.5¢ |
Change
0.010(2.90%) |
Mkt cap ! $17.18M |
Open | High | Low | Value | Volume |
35.0¢ | 36.0¢ | 34.5¢ | $6.75K | 18.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1885 | 29.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
36.5¢ | 100 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1885 | 0.290 |
1 | 2200 | 0.230 |
1 | 20000 | 0.225 |
1 | 4545 | 0.220 |
2 | 6011 | 0.210 |
Price($) | Vol. | No. |
---|---|---|
0.365 | 100 | 1 |
0.380 | 79 | 1 |
0.400 | 1090 | 3 |
0.420 | 23 | 1 |
0.430 | 28 | 1 |
Last trade - 13.02pm 27/09/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |